Kailera makes history with record-breaking $625m IPO
Obesity biotech Kailera Therapeutics has set its sights on the US public market through an upsized $625m IPO, marking one…
Obesity biotech Kailera Therapeutics has set its sights on the US public market through an upsized $625m IPO, marking one…